Form 4: Ecolab Director Michael Larson Reports Stock Option Grant

Ecolab Inc. director Michael Larson reported the acquisition of stock options, with vesting schedules detailed.

Summary

• Michael Larson, a Director at Ecolab Inc., has reported the acquisition of a non-employee director stock option.
• The option grants the right to buy common stock at an exercise price of $247.70.
• The transaction date was May 15, 2026.
• A total of 732 shares are covered by this option.
• The option is exercisable starting August 15, 2026, and expires on May 15, 2036.
• Vesting occurs cumulatively, with 25% of shares vesting at the end of each of the first three three-month periods after the grant date, and the remainder vesting on the last day of the fourth three-month period or the company's next annual meeting date.
• In the event of a Change in Control, the option becomes immediately exercisable in full.
• Larson directly beneficially owns 19,007.5 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard stock option grant to a director, which is typical compensation and not indicative of immediate positive or negative performance changes.

Positives

• Director Michael Larson has been granted stock options, aligning his interests with shareholders.
• The stock option has a long expiration date of May 15, 2036, providing a long-term incentive.
• The option becomes exercisable relatively soon, with the first vesting date on August 15, 2026.

Negatives

• The exercise price of $247.70 is a significant hurdle, requiring a substantial increase in share price for the option to be profitable.
• The vesting schedule is staggered, meaning the full benefit of the option is not realized immediately.

Risks

• The value of the stock option is subject to market fluctuations and the company's future performance.
• A Change in Control event, while potentially beneficial for option holders, could indicate underlying issues within the company.

Future Outlook

The stock option granted to Michael Larson vests over time, with full exercisability dependent on continued service or a change in control, and expires in May 2036.

Management Comments

• The option will become exercisable, on a cumulative basis, as to 25% of the option shares (excluding any fractional portion less than one share), on the last day of each of the first, second and third three-month periods following its date of grant and as to the remaining shares on the earlier of the last day of the fourth three-month period following its date of grant or the company's next annual meeting date; provided, however, that if a Change in Control of the Company (as that term is defined in the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan) will occur, then the option will become immediately exercisable in full.
• The date listed in the Date Exercisable column represents the first vesting date.

Industry Context

StockSavvy.ai notes that the reporting of stock options to directors is a standard practice in the chemicals and water treatment industry, aimed at aligning executive and director compensation with long-term shareholder value.

Stakeholder Impact

• Shareholders: The stock option grant aligns director incentives with long-term shareholder value, potentially leading to decisions that benefit the company's stock price.
• Directors: Michael Larson benefits from the potential appreciation of Ecolab's stock price, subject to the exercise price and vesting schedule.

Next Steps

• Michael Larson may exercise the stock option on or after August 15, 2026, subject to vesting conditions.
• The option will become fully exercisable upon a Change in Control of Ecolab Inc.
• The option expires on May 15, 2036.

Key Dates

Keywords

Ecolab Inc., ECL, Form 4, Stock Option, Director, Beneficial Ownership, SEC Filing, Securities, Executive Compensation, Vesting Schedule